Physicians and patients working through the distressing process of how to best manage pain – both safely and effectively – have good reason to be hopeful. In what comes as ‘very good' health care news, it was announced yesterday that TR Processing, a botanical-derivative manufacturer, served as the Cannabidiol (CBD) supplier for a clinical trial evaluating CBD safety and impact on post-operative pain. More options to best manage pain could be on the horizon.